CorMatrix Cardiovascular
Manufacturing · Georgia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1100 Old Ellis Rd, Roswell, Georgia, 300...Phone Number
(678) 566-2628Website
www.cormatrix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About CorMatrix Cardiovascular
Founded in 2001, based out of Roswell, Georgia, Cormatrix Cardiovascular, Inc., a medical device company, researches, develops, manufactures, and commercializes biomaterial devices that harness the bodys own innate ability to repair damaged heart tissue. The company develops and markets CorMatrix ECM platform technology, an extracellular matrix that helps to remodel, regrow, and restore damaged tissue through signaling the body, providing resistance to infection, enabling complete remodel, and providing long-term strength. Its CorMatrix ECM is used for pericardial repair and reconstruction, cardiac tissue repair, and vascular repair, as well as carotid artery repair. The company also offers CorMatrix ECM envelope to securely hold an implantable electronic device to create a stable environment when implanted in the body.Explore more
Popular SearchesCormatrix CardiovascularCorMatrix Cardiovascular IncCor Matrix Cardiovascular IncCorMatrixCorMatrix Cardiovascular - HomeSIC Code 38,384NAICS Code 33,339Show moreCorMatrix Cardiovascular Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CorMatrix Cardiovascular your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when CorMatrix Cardiovascular launches new products
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CorMatrix Cardiovascular has new funding data
Congratulate Masked Content for being promoted to Masked Content at CorMatrix Cardiovascular
Earning: See what the market has to say on CorMatrix Cardiovascular recently announced quarterly report
Check if CorMatrix Cardiovascular has recently received funding, and reach out quickly before it becomes old news!
CorMatrix Cardiovascular, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if CorMatrix Cardiovascular is spiking on competitors!
Click to see if CorMatrix Cardiovascular had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined CorMatrix Cardiovascular as Masked Content
Find more new buyers
Compare Similar Companies to CorMatrix Cardiovascular
Compare insights from companies similar to CorMatrix Cardiovascular, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CorMatrix Cardiovascular
<$5M
1-10
Private
$24.6M
2001
TF
Ted FalknerDirector, National of Clinical Communication & Training
Company Profile Activity
Activity Insights
CorMatrix Cardiovascular is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CorMatrix Cardiovascular is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CorMatrix Cardiovascular.
CorMatrix Cardiovascular financials insights
Gather financial insights about CorMatrix Cardiovascular, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$24.6M
CorMatrix Cardiovascular Tech Stack
A closer look at the technologies used by CorMatrix Cardiovascular
See more technologies
Most Recent Scoops
Funding
Funding
CorMatrix Cardiovascular recently secured $1 million in an unknown Series funding round.
Funding
Funding
CorMatrix Cardiovascular recently secured $250,000 in an unknown Series funding round.
Funding
Funding
CorMatrix Cardiovascular News & Media
CorMatrix® Cardiovascular, Inc. receives FDA approval to expand and enroll 20 additional patients in the adult arm of its early feasibility IDE study of the Cor® TRICUSPID ECM® valve for pediatric and adult patients
ATLANTA, Feb. 7, 2020 /PRNewswire/ -- CorMatrix®Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced receiving FDA approval to expand and enroll 20 additional patients in the adult arm, including up to 4 additional...CorMatrix® Cardiovascular, Inc. announces the first minimally invasive robotic implant of Cor® PATCH for epicardial support and repair
CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announces the first minimally invasive robotic implant of Cor® PATCH by Dr. Husam H. Balkhy, Professor of Surgery, and Director of Robotic and Minimally Invasive Cardiac Surgery at the University of Chicago Medicine. Dr. Balkhy is a global leader and pioneer in minimally invasive and robotic cardiac surgery with extensive experience performing robotic totally endoscopic beCorMatrix® Cardiovascular, Inc. completes enrollment of adult arm of its FDA early feasibility IDE study for the Cor® TRICUSPID ECM® valve for pediatric and adult patients
ATLANTA, Sept. 26, 2019 /PRNewswire/ -- CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced it has completed enrollment of the adult arm of its FDA early feasibility IDE study for the Cor® TRICUSPID ECM®...CorMatrix® Cardiovascular, Inc. receives FDA 510(k) clearance to market the Cor™ PATCH epicardial patch for tissue support and repair in adult patients
ATLANTA, June 11, 2019 /PRNewswire/ -- CorMatrix® Cardiovascular, Inc. www.cormatrix.com, a leading developer of regenerative cardiovascular medical devices, today announced FDA 510(k) clearance for the Cor™ PATCH. The Cor™ PATCH is indicated for epicardial tissue support and repair in...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CorMatrix Cardiovascular
Sign Up For FreeTo access detailed company insights
Founded in 2001, based out of Roswell, Georgia, Cormatrix Cardiovascular, Inc., a medical device company, researches, develops, manufactures, and commercializes biomaterial devices that harness the bodys own innate ability to repair damaged heart tissue. The company develops and markets CorMatrix ECM platform technology, an extracellular matrix tha... Read More
